Hadiza S Kazaure1, Molinda Martin2, Jung K Yoon2, Sherry M Wren3. 1. Department of General Surgery, Stanford University School of Medicine, Stanford, California. 2. Veterans Affairs Palo Alto Health Care System, Palo Alto, California. 3. Department of General Surgery, Stanford University School of Medicine, Stanford, California2Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
Abstract
IMPORTANCE: Pneumonia is the third most common complication in postoperative patients and is associated with significant morbidity and high cost of care. Prevention has focused primarily on mechanically ventilated patients. This study outlines the results of the longest-running postoperative pneumonia prevention program for nonmechanically ventilated patients, to our knowledge. OBJECTIVE: To present long-term results (2008-2012) of a standardized postoperative ward-acquired pneumonia prevention program introduced in 2007 on the surgical ward of our hospital and compare our postintervention pneumonia rates with those captured in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). We also estimate the cost savings attributable to the pneumonia prevention program. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study at a university-affiliated Veterans Affairs hospital of all noncardiac surgical patients with ward-acquired postoperative pneumonia. INTERVENTION: A previously described standardized postoperative pneumonia prevention program for patients on the surgical ward. MAIN OUTCOME AND MEASURE: Ward-acquired postoperative pneumonia. RESULTS: Between 2008 and 2012, there were 18 cases of postoperative pneumonia among 4099 at-risk patients hospitalized on the surgical ward, yielding a case rate of 0.44%. This represents a 43.6% decrease from our preintervention rate (0.78%) (P = .01). The pneumonia rates in all years were lower than the preintervention rate (0.25%, 0.50%, 0.58%, 0.68%, and 0.13% in 2008-2012, respectively). The overall pneumonia rate in ACS-NSQIP was 2.56% (14,033 cases of pneumonia among 547,571 at-risk patients), which is 582% higher than the postintervention rate at our ward. Using a national average of $46,400 in attributable health care cost of postoperative pneumonia and a benchmark of a 43.6% decrease in pneumonia rate achieved at our facility over the 5-year study period, a similar percentage of decrease in pneumonia occurrence at ACS-NSQIP hospitals would represent approximately 6118 prevented pneumonia cases and a cost savings of more than $280 million. CONCLUSIONS AND RELEVANCE: The standardized pneumonia prevention program achieved substantial and sustained reduction in postoperative pneumonia incidence on our surgical ward; its wider adoption could improve postoperative outcomes and reduce overall health care costs.
IMPORTANCE: Pneumonia is the third most common complication in postoperative patients and is associated with significant morbidity and high cost of care. Prevention has focused primarily on mechanically ventilated patients. This study outlines the results of the longest-running postoperative pneumonia prevention program for nonmechanically ventilated patients, to our knowledge. OBJECTIVE: To present long-term results (2008-2012) of a standardized postoperative ward-acquired pneumonia prevention program introduced in 2007 on the surgical ward of our hospital and compare our postintervention pneumonia rates with those captured in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). We also estimate the cost savings attributable to the pneumonia prevention program. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study at a university-affiliated Veterans Affairs hospital of all noncardiac surgical patients with ward-acquired postoperative pneumonia. INTERVENTION: A previously described standardized postoperative pneumonia prevention program for patients on the surgical ward. MAIN OUTCOME AND MEASURE: Ward-acquired postoperative pneumonia. RESULTS: Between 2008 and 2012, there were 18 cases of postoperative pneumonia among 4099 at-risk patients hospitalized on the surgical ward, yielding a case rate of 0.44%. This represents a 43.6% decrease from our preintervention rate (0.78%) (P = .01). The pneumonia rates in all years were lower than the preintervention rate (0.25%, 0.50%, 0.58%, 0.68%, and 0.13% in 2008-2012, respectively). The overall pneumonia rate in ACS-NSQIP was 2.56% (14,033 cases of pneumonia among 547,571 at-risk patients), which is 582% higher than the postintervention rate at our ward. Using a national average of $46,400 in attributable health care cost of postoperative pneumonia and a benchmark of a 43.6% decrease in pneumonia rate achieved at our facility over the 5-year study period, a similar percentage of decrease in pneumonia occurrence at ACS-NSQIP hospitals would represent approximately 6118 prevented pneumonia cases and a cost savings of more than $280 million. CONCLUSIONS AND RELEVANCE: The standardized pneumonia prevention program achieved substantial and sustained reduction in postoperative pneumonia incidence on our surgical ward; its wider adoption could improve postoperative outcomes and reduce overall health care costs.
Authors: Kwaku Owusu-Bediako; Kayla Pfaff; Nguyen K Tram; David L Stahl; Joseph D Tobias; Olubukola O Nafiu; Christian Mpody Journal: J Clin Med Res Date: 2022-06-27
Authors: Varun Puri; Aalok P Patel; Traves D Crabtree; Jennifer M Bell; Stephen R Broderick; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan F Meyers Journal: J Thorac Cardiovasc Surg Date: 2015-08-28 Impact factor: 5.209
Authors: Morad Chughtai; Chukwuweike U Gwam; Nequesha Mohamed; Anton Khlopas; Jared M Newman; Rafay Khan; Ali Nadhim; Shervin Shaffiy; Michael A Mont Journal: J Clin Med Res Date: 2017-04-26
Authors: Antonio Klasan; Philipp Dworschak; Thomas Jan Heyse; Steffen Ruchholtz; Peter Alter; Claus Franz Vogelmeier; Patrick Schwarz Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-08-21
Authors: Ana López-de-Andrés; Napoleon Perez-Farinos; Javier de Miguel-Díez; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; Manuel Méndez-Bailón; José M de Miguel-Yanes; Rodrigo Jiménez-García Journal: PLoS One Date: 2019-02-06 Impact factor: 3.240
Authors: Marco Vincenzo Lenti; Caterina Mengoli; Marta Vernero; Nicola Aronico; Laura Conti; Federica Borrelli de Andreis; Sara Cococcia; Antonio Di Sabatino Journal: Front Immunol Date: 2020-03-23 Impact factor: 7.561